Timothy Isham Shaw

1 Patent

• US125707302026

  Chimeric Antigen Receptors for Direct and Indirect Targeting of Fibronectin-positive Tumors

  ST. JUDE CHILDREN'S RESEARCH HOSPITAL, Inc.

  0 cites